Mallinckrodt sells CMDS business to Guerbet for $270 million

November 28, 2015

Mallinckrodt plc, a leading specialty biopharmaceutical company, announced today that it has closed the sale of its global contrast media and delivery systems (CMDS) business to Guerbet in a transaction valued at approximately $270 million.

Previous Article
Family Research Council strongly condemns shooting at Planned Parenthood center
Family Research Council strongly condemns shooting at Planned Parenthood center

Family Research Council President Tony Perkins released the following statement regarding the shooting at a...

Next Article
ClinicAll's innovative software solution provides flexible access to patient health records
ClinicAll's innovative software solution provides flexible access to patient health records

The health system is set to go online. The potential to save costs, improve treatment quality and accelerat...